Two years into a pandemic that has wreaked havoc in Japan and around the world, some experts believe the endgame may be in sight.
That optimism is largely due to improved treatment options, a high vaccination rate and the milder nature of the omicron variant, which has spurred an unprecedented rise in cases nationwide but has a fatality rate that, if early data holds, may even be roughly on par with influenza.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.